Annual EBITDA
$921.76M$203.00M+28.24%
Summary
- Current Value
- As of today, EXEL annual EBITDA is $921.76M, up +28.24% on
- Historical Performance
- EXEL annual EBITDA is up +314.54% over the past 3 years, up +643.17% over the past 5 years
- All-Time High Comparison
- EXEL annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL annual EBITDA is +368.84% above its 3-year low of $196.60M reached on
- Sector Comparison
- EXEL annual EBITDA is higher than 93.11% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $921.76M | +28.2% | +314.5% | +643.2% | +2015.9% | |
| Quarterly EBITDA | $258.29M | +33.0% | +508.9% | +10000.0% | +1616.3% | |
| TTM EBITDA | $985.84M | +16.8% | +425.5% | +1355.9% | +3020.3% | |
| Price | $49.13 | +12.4% | +148.3% | +100.9% | +333.3% | |
| PE Ratio | 16.28 | -17.9% | -61.2% | -86.7% | – | |
| Annual Revenue | $2.32B | +7.0% | +44.0% | +134.9% | +1153.8% | |
| Annual EPS | $2.78 | +57.7% | +394.4% | +689.9% | +426.6% | |
| $892.70M | +29.4% | +343.1% | +711.1% | +1622.0% | ||
| Annual Net Income | $782.57M | +50.1% | +329.3% | +600.1% | +947.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $921.76M | at high | |
| 5Y | $921.76M | at high | |
| All | $921.76M | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $196.60M | +368.8% | |
| 5Y | $124.03M | N/A | +643.2% |
| All | -$214.97M | +528.8% |
EBITDA History
FAQ
What is the current annual EBITDA of EXEL?
As of today, EXEL annual EBITDA is $921.76M
What is 1-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +28.24% year-over-year
What is 3-year change in EXEL annual EBITDA?
EXEL annual EBITDA is up +314.54% over the past 3 years
How far is EXEL annual EBITDA from its all-time high?
EXEL annual EBITDA is currently at its all-time high
How does EXEL annual EBITDA rank versus sector peers?
EXEL annual EBITDA is higher than 93.11% of companies in Healthcare sector
When is EXEL next annual earnings release?
As of today, the next annual earnings release for EXEL has not been scheduled
Quarterly EBITDA
$258.29M$15.43M+6.35%
Summary
- Current Value
- As of today, EXEL quarterly EBITDA is $258.29M, up +6.35% on
- Historical Performance
- EXEL quarterly EBITDA is up +33.00% year-over-year, up +508.94% over the past 3 years
- All-Time High Comparison
- EXEL quarterly EBITDA is currently -8.95% below its historical high of $283.68M set on
- 3-Year Low Comparison
- EXEL quarterly EBITDA is +2388.38% above its 3-year low of -$11.29M reached on
- Sector Comparison
- EXEL quarterly EBITDA is higher than 93.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $258.29M | +6.3% | +33.0% | +508.9% | +10000.0% | |
| Annual EBITDA | $921.76M | – | +28.2% | +314.5% | +643.2% | |
| TTM EBITDA | $985.84M | +7.0% | +16.8% | +425.5% | +1355.9% | |
| Price | $49.13 | +12.6% | +12.4% | +148.3% | +100.9% | |
| PE Ratio | 16.28 | +3.9% | -17.9% | -61.2% | -86.7% | |
| Quarterly Revenue | $610.81M | +2.0% | +10.0% | +49.4% | +126.0% | |
| Quarterly EPS | $0.79 | -11.0% | +42.1% | +541.6% | +10000.0% | |
| $251.34M | +6.5% | +34.5% | +771.8% | +5555.6% | ||
| Quarterly Net Income | $210.47M | -13.9% | +31.9% | +425.8% | +10000.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $263.78M | -2.1% | |
| 3Y | $283.68M | -8.9% | |
| 5Y | $283.68M | -8.9% | |
| All | $283.68M | -8.9% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $194.20M | N/A | +33.0% |
| 3Y | -$11.29M | +2388.4% | |
| 5Y | -$42.13M | +713.0% | |
| All | -$64.44M | +500.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of EXEL?
As of today, EXEL quarterly EBITDA is $258.29M
What is EXEL quarterly EBITDA most recent change?
EXEL quarterly EBITDA was up +6.35% on March 1, 2026
What is 1-year change in EXEL quarterly EBITDA?
EXEL quarterly EBITDA is up +33.00% year-over-year
How far is EXEL quarterly EBITDA from its all-time high?
EXEL quarterly EBITDA is currently -8.95% below its historical high of $283.68M set on June 28, 2024
How does EXEL quarterly EBITDA rank versus sector peers?
EXEL quarterly EBITDA is higher than 93.07% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
TTM EBITDA
$985.84M$64.09M+6.95%
Summary
- Current Value
- As of today, EXEL TTM EBITDA is $985.84M, up +6.95% on
- Historical Performance
- EXEL TTM EBITDA is up +16.77% year-over-year, up +425.54% over the past 3 years
- All-Time High Comparison
- EXEL TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- EXEL TTM EBITDA is +1130.21% above its 3-year low of $80.14M reached on
- Sector Comparison
- EXEL TTM EBITDA is higher than 93.07% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $985.84M | +7.0% | +16.8% | +425.5% | +1355.9% | |
| Annual EBITDA | $921.76M | – | +28.2% | +314.5% | +643.2% | |
| Quarterly EBITDA | $258.29M | +6.3% | +33.0% | +508.9% | +10000.0% | |
| Price | $49.13 | +12.6% | +12.4% | +148.3% | +100.9% | |
| PE Ratio | 16.28 | +3.9% | -17.9% | -61.2% | -86.7% | |
| TTM Revenue | $2.38B | +2.4% | +3.3% | +42.8% | +130.4% | |
| TTM EPS | $3.02 | +8.4% | +36.9% | +539.1% | +1407.1% | |
| $957.18M | +7.2% | +17.5% | +550.8% | +1718.2% | ||
| TTM Net Income | $833.42M | +6.5% | +29.5% | +442.1% | +1186.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $985.84M | at high | |
| 3Y | $985.84M | at high | |
| 5Y | $985.84M | at high | |
| All | $985.84M | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $781.52M | +26.1% | |
| 3Y | $80.14M | +1130.2% | |
| 5Y | $67.71M | N/A | +1355.9% |
| All | -$238.61M | +513.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of EXEL?
As of today, EXEL TTM EBITDA is $985.84M
What is EXEL TTM EBITDA most recent change?
EXEL TTM EBITDA was up +6.95% on March 1, 2026
What is 1-year change in EXEL TTM EBITDA?
EXEL TTM EBITDA is up +16.77% year-over-year
How far is EXEL TTM EBITDA from its all-time high?
EXEL TTM EBITDA is currently at its all-time high
How does EXEL TTM EBITDA rank versus sector peers?
EXEL TTM EBITDA is higher than 93.07% of companies in Healthcare sector
When is EXEL next earnings release?
The next earnings release for EXEL is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- EXEL Official Website www.exelixis.com
- EXEL Profile on Yahoo Finance finance.yahoo.com/quote/EXEL
- EXEL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exel